No Data
GTJA: The new paradigm reshapes the drug development landscape, and the cycle of inventory reduction for Active Pharmaceutical Ingredient is approaching its end.
The CXO adjustments are nearing completion, and the Industry is moving towards the development stage 2.0; the API destocking cycle is coming to an end, seizing opportunities for industrial transformation.
Hong Kong stocks fluctuated | CRO Concept stocks continued to surge in the morning, WUXI BIO (02269) and TIGERMED (03347) both rose over 9%.
In the early session, CRO Concept stocks continued to rise. As of the time of writing, WUXI BIO (02269) is up 9.59%, priced at 22.85 HKD; TIGERMED (03347) is up 9.09%, priced at 31.2 HKD; GENSCRIPT BIO (01548) is up 7.22%, priced at 11.88 HKD.
The MSCI Chinese Index has newly included J&T Express (01519) and 8 other Stocks.
Jingwu Financial News | MSCI announced the results of the index review for February. The MSCI Chinese Index added Bestechnic (Shanghai) Co., Ltd., China National Agricultural Development Group, Canadian Solar, J&T Express (01519), Jiangsu Hoperun Software, JinkoSolar, Sichuan Changhong Electric, and Yonghui Superstores, while it removed Anjoy Foods Group, Autobio Diagnostics, Bloomage Biotechnology Corporation Limited, Asymchem Laboratories (06821), Shan Xi Hua Yang Group New Energy, and 20 other Stocks. The adjustments will take effect after the close on February 28.
Hong Kong stock early report on February 12: Contemporary Amperex Technology submitted its IPO application for the Hong Kong stock market, and the Hong Kong General Chamber of Commerce proposed to relax the thresholds for the 'southbound trading' scheme.
① Contemporary Amperex Technology submitted its IPO application for the Hong Kong Stock Exchange. ② The Hong Kong General Chamber of Commerce proposed to relax the investment threshold for 'Southbound Trading' investors. ③ Powell stated that the Federal Reserve has no reason to rush into cutting interest rates. ④ AI has sparked interest in Hong Kong stocks, prompting fund managers to allocate resources to chase this trend.
Asymchem Laboratories (Tianjin) Insiders Placed Bullish Bets Worth CN¥6.66m
Asymchem Laboratories (002821.SZ): has repurchased a total of 3.616% of its shares.
Guangdong Stock Exchange February 6丨Asymchem Laboratories (002821.SZ) announced that as of January 31, 2025, the company has repurchased a total of 12,300,701 shares through a dedicated securities account in a centralized bidding manner, accounting for 3.6161% of the company's total A-share capital, with the highest Fill Price being 102.00 yuan/share, the lowest Fill Price being 71.65 yuan/share, and the total amount paid being 0.9996 billion yuan (excluding transaction fees).
Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Stock Catapults 26% Though Its Price And Business Still Lag The Market
